Harry Hyman — Management
Get alerts when Harry Hyman trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: BioPharma Credit plc.
12-month summary
No open-market buys or sales in the last 12 months
0 open-market buys, 0 sales, 0 share awards
Roles
03.11.2025 – 31.07.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 31.07.2026 | BioPharma Credit plc London | Dividend reinvestmentAcquisition via Anita Hyman | 76 | GBP 0.72 | GBP 54.82 | Source: UK National Storage Mechanism · 03.08.2026 |
| 29.05.2026 | BioPharma Credit plc London | Dividend reinvestmentAcquisition via Anita Hyman | 75 | GBP 0.72 | GBP 53.70 | Source: UK National Storage Mechanism · 01.06.2026 |
| 23.03.2026 | BioPharma Credit plc London | Dividend reinvestmentAcquisition via Anita Hyman | 137 | GBP 0.70 | GBP 96.08 | Source: UK National Storage Mechanism · 16.04.2026 |
| 03.11.2025 | BioPharma Credit plc London | Dividend reinvestmentAcquisition via Anita Hyman | 62 | GBP 0.69 | GBP 43.00 | Source: UK National Storage Mechanism · 04.11.2025 |
Other insiders with this name
These records share this name but haven't been confirmed as the same person — shown so you can judge for yourself.